Post-mortem human AD brain samples showed distinct aberrant expression of m6A methyltransferases where METTL3 and the RNA-binding motif protein 15B (RBM15B) were downregulated and upregulated in the hippocampus, respectively. Here, METTL3 is linked to Alzheimer disease.